American College of Obstetricians and Gynecologists Committee on Practice Bulletins–Gynecology. ACOG Practice Bulletin No. 200: early pregnancy loss. Obstet Gynecol. 2018;132(5):e197-e207.
- Landon MB, Galan H, Jauniaux E, et al. Gabbe’s Obstetrics: Normal and Problem Pregnancies. 8th ed. Elsevier; 2021.
Hendriks E, MacNaughton H, MacKenzie MC. First trimester bleeding: evaluation and management. Am Fam Physician. 2019;99(3):166-174.
VanArendonk SH, Rockhill K, Stickrath EH, Alston MJ. Evaluation of early pregnancy concerns in an early pregnancy unit compared with an emergency department. Obstet Gynecol. 2020;136(5):995-1000.
Hasan R, Baird DD, Herring AH, Olshan AF, Jonsson Funk ML, Hartmann KE. Association between first-trimester vaginal bleeding and miscarriage. Obstet Gynecol. 2009;114(4):860-867.
Sapra KJ, Joseph KS, Galea S, Bates LM, Louis GM, Ananth CV. Signs and symptoms of early pregnancy loss: a systemic review. Reprod Sci. 2017;24(4):502-513.
Bever AM, Pugh SJ, Kim S. Fetal growth patterns in pregnancies with first-trimester bleeding. Obstet Gynecol. 2018;131(6):1021-1030.
Lykke JA, Dideriksen KL, Lidegaard Ø, Langhoff-Roos J. First-trimester vaginal bleeding and complications later in pregnancy. Obstet Gynecol. 2010;115(5):935-944.
Naert MN, Khadraoui H, Muniz Rodriguez A, Naqvi M, Fox NS. Association between first-trimester subchorionic hematomas and pregnancy loss in singleton pregnancies. Obstet Gynecol. 2019;134(2):276-281.
Doubilet PM, Benson CB, Bourne T, Blaivas M; Society of Radiologists in Ultrasound Multispecialty Panel on Early First Trimester Diagnosis of Miscarriage and Exclusion of a Viable Intrauterine Pregnancy. Diagnostic criteria for nonviable pregnancy early in the first trimester. N Engl J Med. 2013;369(15):1443-1451.
AIUM-ACR-ACOG-SMFM-SRU practice parameter for the performance of standard diagnostic obstetric ultrasound examinations. J Ultrasound Med. 2018;37(11):E13-E24.
- American Academy of Family Physicians (AAFP). Obstetric Ultrasound Examination (Position Paper). 2018. https://www.aafp.org/about/policies/all/obstetric-ultrasound.html
Wang R, Reynolds TA, West HH. Use of a beta-hCG discriminatory zone with bedside pelvic ultrasonography. Ann Emerg Med. 2011;58(1):12-20.
American College of Obstetricians and Gynecologists’ Committee on Practice Bulletins–Gynecology. ACOG Practice Bulletin No. 193: tubal ectopic pregnancy. Obstet Gynecol. 2018;131(3):e91-e103.
Verhaegen J, Gallos ID, van Mello NM. Accuracy of single progesterone test to predict early pregnancy outcome in women with pain or bleeding: meta-analysis of cohort studies. BMJ. 2012;345:e6077.
Nanda K, Lopez LM, Grimes DA, Peloggia A, Nanda G. Expectant care versus surgical treatment for miscarriage [Review]. Cochrane Database Syst Rev. 2012(3):CD003518.
Henkel A, Shaw KA. Advances in the management of early pregnancy loss. Curr Opin Obstet Gynecol. 2018;30(6):419-424.
US Food and Drug Administration. Mifeprex information. https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/mifeprex-mifepristone-information
Devall AJ, Papadopoulou A, Podesek M. Progestogens for preventing miscarriage: a network meta-analysis [Review]. Cochrane Database Syst Rev. 2021(4):CD013792.
Abenhaim HA. Progesterone for prevention of miscarriage and preterm birth in women with first-trimester bleeding: PREEMPT trial. Am J Obstet Gynecol. 2022;139(5):226 , Abstract A260.
Coomarasamy A, Devall AJ, Brosens JJ. Micronized vaginal progesterone to prevent miscarriage: a critical evaluation of randomized evidence. Am J Obstet Gynecol. 2020;223(2):167-176.
American College of Obstetricians and Gynecologists’ Committee on Practice Bulletins–Obstetrics. ACOG Practice Bulletin No. 181: prevention of Rh D alloimmunization. Obstet Gynecol. 2017;130(2):e57-e70.
American College of Obstetricians and Gynecologists’ Committee on Practice Bulletins–Obstetrics. ACOG Practice Bulletin No. 192: management of alloimmunization during pregnancy. Obstet Gynecol. 2018;131(3):e82-e90.
Aleman A, Althabe F, Belizán J, Bergel E. Bed rest during pregnancy for preventing miscarriage [Review]. Cochrane Database Syst Rev. 2005(2):CD003576.
McCall CA, Grimes DA, Lyerly AD. “Therapeutic” bed rest in pregnancy: unethical and unsupported by data. Obstet Gynecol. 2013;121(6):1305-1308.
Practice Committee of the American Society for Reproductive Medicine. Evaluation and treatment of recurrent pregnancy loss: a committee opinion. Fertil Steril. 2012;98(5):1103-1111.
Lin T, Chen Y, Cheng X, Li N, Sheng X. Enoxaparin (or plus aspirin) for the prevention of recurrent miscarriage: a meta-analysis of randomized controlled studies. Eur J Obstet Gynecol Reprod Biol. 2019;234:53-57.
de Jong PG, Kaandorp S, Di Nisio M, Goddijn M, Middeldorp S. Aspirin and/or heparin for women with unexplained recurrent miscarriage with or without inherited thrombophilia [Review]. Cochrane Database Syst Rev. 2014(7):CD004734.
Clement EG, Horvath S, McAllister A, Koelper NC, Sammel MD, Schreiber CA. The language of first-trimester nonviable pregnancy: Patient-reported preferences and clarity. Obstet Gynecol. 2019;133(1):149-154.
American Diabetes Association. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes 2021. Diabetes Care. 2021;44(Suppl 1):S15-S33.
Coustan DR, Dyer AR, Metzger BE. One-step or 2-step testing for gestational diabetes: which is better?. Am J Obstet Gynecol. 2021;225(6):634-644.
Hillier TA, Pedula KL, Ogasawara KK. A pragmatic, randomized clinical trial of gestational diabetes screening. N Engl J Med. 2021;384(10):895-904.
Raets L, Beunen K, Benhalima K. Screening for gestational diabetes mellitus in early pregnancy: what Is the evidence?. J Clin Med. 2021;10(6):1257.
Concepción Zavaleta MJ, Coronado Arroyo JC, Zavaleta Gutiérrez FE, Concepción Urteaga LA. Gestational diabetes during COVID 19 pandemic: major problem is diagnosis. Diabetes Metab Syndr. 2021;15(3):1051-1052.
Bogdanet D, O’Shea P, Lyons C, Shafat A, Dunne F. The oral glucose tolerance test—is it time for a change? A literature review with an emphasis on pregnancy. J Clin Med. 2020;9(11):E3451.
American College of Obstetricians and Gynecologists’ Committee on Practice Bulletins–Obstetrics. ACOG Practice Bulletin No. 190: gestational diabetes mellitus. Obstet Gynecol. 2018;131(2):e49-e64.
Zhang Y, Xiao CM, Zhang Y. Factors associated with gestational diabetes mellitus: a meta-analysis. J Diabetes Res. 2021;2021:6692695.
Davidson KW, Barry MJ, Mangione CM; US Preventive Services Task Force. Screening for gestational diabetes: US Preventive Services Task Force recommendation statement. JAMA. 2021;326(6):531-538.
Figueroa D, Landon MB, Mele L. Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Maternal-Fetal Medicine Units (MFMU) Network. Relationship between 1-hour glucose challenge test results and perinatal outcomes. Obstet Gynecol. 2013;121(6):1241-1247.
Davitt C, Flynn KE, Harrison RK, Pan A, Palatnik A. Current practices in gestational diabetes mellitus diagnosis and management in the United States: survey of maternal-fetal medicine specialists. Am J Obstet Gynecol. 2021;225(2):203-204.
Magon N, Chauhan M. Pregnancy in type 1 diabetes mellitus: how special are special issues?. N Am J Med Sci. 2012;4(6):250-256.
American Diabetes Association. 13. Management of diabetes in pregnancy. Diabetes Care. 2017;40(Suppl 1):S114-S119.
Davidson KW, Barry MJ, Mangione CM; US Preventive Services Task Force. Behavioral counseling interventions for healthy weight and weight gain in pregnancy: US Preventive Services Task Force recommendation statement. JAMA. 2021;325(20):2087-2093.
American College of Obstetricians and Gynecologists’ Committee on Practice Bulletins–Obstetrics. I. Obesity in Pregnancy: ACOG Practice Bulletin, Number 230. Obstet Gynecol. 2021;137(6):e128-e144.
Schiattarella A, Lombardo M, Morlando M, Rizzo G. The impact of a plant-based diet on gestational diabetes: a review. Antioxidants. 2021;10(4):557.
American Diabetes Association. 14. Management of Diabetes in Pregnancy: Standards of Medical Care in Diabetes 2021. Diabetes Care. 2021;44(Suppl 1):S200-S210.
Gilmartin AB, Ural SH, Repke JT. Gestational diabetes mellitus. Rev Obstet Gynecol. 2008;1(3):129-134.
Society of Maternal-Fetal Medicine (SMFM) Publications Committee. SMFM Statement: pharmacological treatment of gestational diabetes. Am J Obstet Gynecol. 2018;218(5):B2-B4.
Brand KMG, Saarelainen L, Sonajalg J; CLUE Study Group. Metformin in pregnancy and risk of adverse long-term outcomes: a register-based cohort study. BMJ Open Diabetes Res Care. 2022;10(1):e002363.
American College of Obstetricians and Gynecologists’ Committee on Practice Bulletins–Obstetrics. ACOG Practice Bulletin No. 229: antepartum fetal surveillance. Obstet Gynecol. 2021;137(6):e116-e127.
Berger H, Melamed N. Timing of delivery in women with diabetes in pregnancy. Obstet Med. 2014;7(1):8-16.
Yeh T, Yeung M, Mendelsohn Curanaj FA. I. Inpatient glycemic management of the pregnant patient. Curr Diab Rep. 2018;18(10):73.
Hamel MS, Kanno LM, Has P, Beninati MJ, Rouse DJ, Werner EF. Intrapartum glucose management in women with gestational diabetes mellitus: a randomized controlled trial. Obstet Gynecol. 2019;133(6):1171-1177.
American College of Obstetricians and Gynecologists’ Committee on Practice Bulletins–Obstetrics. I. ACOG Practice Bulletin No. 201: pregestational Diabetes Mellitus. Obstet Gynecol. 2018;132(6):e228-e248.
Lende M, Rijhsinghani A. Gestational diabetes: overview with emphasis on medical management. Int J Environ Res Public Health. 2020;17(24):9573.
Thompson-Branch A, Havranek TI. Neonatal hypoglycemia. Pediatr Rev. 2017;38(4):147-157.
Cordero L, Treuer SH, Landon MB, Gabbe SG. Management of infants of diabetic mothers. Arch Pediatr Adolesc Med. 1998;152(3):249-254.
Mitanchez D, Yzydorczyk C, Simeoni U. What neonatal complications should the pediatrician be aware of in case of maternal gestational diabetes?. World J Diabetes. 2015;6(5):734-743.
Chasan-Taber L. Lifestyle interventions to reduce risk of diabetes among women with prior gestational diabetes mellitus. Best Pract Res Clin Obstet Gynaecol. 2015;29(1):110-122.
Aroda VR, Christophi CA, Edelstein SL; Diabetes Prevention Program Research Group. The effect of lifestyle intervention and metformin on preventing or delaying diabetes among women with and without gestational diabetes: the Diabetes Prevention Program outcomes study 10-year follow-up. J Clin Endocrinol Metab. 2015;100(4):1646-1653.
Rautio N, Jokelainen J, Korpi-Hyövälti E. Lifestyle intervention in prevention of type 2 diabetes in women with a history of gestational diabetes mellitus: one-year results of the FIN-D2D project. J Womens Health (Larchmt). 2014;23(6):506-512.
Martins JG, Biggio JR, Abuhamad A; Society for Maternal-Fetal Medicine (SMFM). Society for Maternal-Fetal Medicine Consult Series #52: diagnosis and management of fetal growth restriction: (Replaces Clinical Guideline Number 3, April 2012). Am J Obstet Gynecol. 2020;223(4):B2-B17.
American College of Obstetricians and Gynecologists’ Committee on Practice Bulletins–Obstetrics and Society for Maternal-Fetal Medicine. ACOG Practice Bulletin No. 227: fetal growth restriction. Obstet Gynecol. 2021;137(2):e16-e28.
Lees CC, Marlow N, van Wassenaer-Leemhuis A; TRUFFLE study group. 2 year neurodevelopmental and intermediate perinatal outcomes in infants with very preterm fetal growth restriction (TRUFFLE): a randomised trial. Lancet. 2015;385(9983):2162-2172.
Royal College of Obstetricians asnd Gynaecologists. The investigation and management of the small-for-gestational-age fetus (Green-top Guideline No. 31). https://www.rcog.org.uk/media/t3lmjhnl/gtg_31.pdf
Society for Obstericians and Gynaecologists of Canada. Committee Opinion No. 400: COVID-19 and pregnancy. https://www.sogc.org/common/Uploaded%20files/Media%20Updates/EN_Statement-COVID_Pregnancy.pdf
Society for Maternal-Fetal Medicine (SMFM) COVID Task Force. COVID-19 and pregnancy: what maternal-fetal medicine sub-specialists need to know. https://s3.amazonaws.com/cdn.smfm.org/media/3402/COVID19-What_MFMs_need_to_know_revision_3-1-22_%28final%29.pdf
Pilliod RA, Cheng YW, Snowden JM, Doss AE, Caughey AB. The risk of intrauterine fetal death in the small-for-gestational-age fetus. Am J Obstet Gynecol. 2012;207(4):318 e1-6.
Baschat AA, Cosmi E, Bilardo CM. Predictors of neonatal outcome in early-onset placental dysfunction. Obstet Gynecol. 2007;109(2 Pt 1):253-261.
Chen J, Chen P, Bo T, Luo K. Cognitive and behavioral outcomes of intrauterine growth restriction school-age children. Pediatrics. 2016;137(4):e20153868.
Leitner Y, Fattal-Valevski A, Geva R. Neurodevelopmental outcome of children with intrauterine growth retardation: a longitudinal, 10-year prospective study. J Child Neurol. 2007;22(5):580-587.
Lausman A, Kingdom J; Maternal Fetal Medicine Committee. Intrauterine growth restriction: screening, diagnosis, and management. J Obstet Gynaecol Can. 2013;35(8):741-748.
American College of Obstetricians and Gynecologists. Committee on Practice Bulletins–Obstetrics and the Society for Maternal-Fetal Medicine. ACOG Practice Bulletin No. 231: multifetal gestations: twin, triplet, and higher-order multifetal pregnancies. Obstet Gynecol. 2021;137(6):e145-e162.
David C, Gabrielli S, Pilu G, Bovicelli L. The head-to-abdomen circumference ratio: a reappraisal. Ultrasound Obstet Gynecol. 1995;5(4):256-259.
Melamed N, Baschat A, Yinon Y. FIGO (International Federation of Gynecology and Obstetrics) initiative on fetal growth: best practice advice for screening, diagnosis, and management of fetal growth restriction. Int J Gynaecol Obstet. 2021;152(Suppl 1):3-57.
Kiserud T, Piaggio G, Carroli G. The World Health Organization fetal growth charts: a multinational longitudinal study of ultrasound biometric measurements and estimated fetal weight. PLoS Med. 2017;14(1):e1002220.
Papageorghiou AT, Ohuma EO, Altman DG; International Fetal and Newborn Growth Consortium for the 21st Century (INTERGROWTH-21st). International standards for fetal growth based on serial ultrasound measurements: the Fetal Growth Longitudinal Study of the INTERGROWTH-21st Project. Lancet. 2014;384(9946):869-879.
Buck Louis GM, Grewal J, Albert P. Racial/ethnic standards for fetal growth: the NICHD Fetal Growth Studies. Am J Obstet Gynecol. 2015;213(4):449 e1-449 e41.
Carberry AE, Gordon A, Bond DM, Hyett J, Raynes-Greenow CH, Jeffery HE. Customised versus population-based growth charts as a screening tool for detecting small for gestational age infants in low-risk pregnant women [Review]. Cochrane Database Syst Rev. 2014(5):CD008549.
Blue NR, Beddow ME, Savabi M, Katukuri VR, Chao CR. Comparing the Hadlock fetal growth standard to the Eunice Kennedy Shriver National Institute of Child Health and Human Development racial/ethnic standard for the prediction of neonatal morbidity and small for gestational age. Am J Obstet Gynecol. 2018;219(5):474 e1-474 e12.
Robert Peter J, Ho JJ, Valliapan J, Sivasangari S. Symphysial fundal height (SFH) measurement in pregnancy for detecting abnormal fetal growth [Review]. Cochrane Database Syst Rev. 2015(9):CD008136.
Milner J, Arezina J. The accuracy of ultrasound estimation of fetal weight in comparison to birth weight: a systematic review. Ultrasound. 2018;26(1):32-41.
Alfirevic Z, Stampalija T, Dowswell T. Fetal and umbilical Doppler ultrasound in high-risk pregnancies [Review]. Cochrane Database Syst Rev. 2017(6):CD007529.
American College of Obstetricians and Gynecologists’ Committee on Obstetric Practice. Society for Maternal-Fetal Medicine. I. Medically indicated late-preterm and early-term deliveries: ACOG Committee Opinion, Number 831. Obstet Gynecol. 2021;138(1):e35-e39.
Committee on Obstetric Practice. Committee Opinion No. 713: antenatal corticosteroid therapy for fetal maturation. Obstet Gynecol. 2017;130(2):e102-e109.
Davidson KW, Barry MJ, Mangione CM; US Preventive Services Task Force. Aspirin use to prevent preeclampsia and related morbidity and mortality: US Preventive Services Task Force recommendation statement. JAMA. 2021;326(12):1186-1191.
American College of Obstetricians and Gynecologists’ Committee on Obstetric Practice and the Society for Maternal-Fetal Medicine. ACOG Committee Opinion No. 743: low-dose aspirin use during pregnancy. Obstet Gynecol. 2018;132(1):e44-e52.
Signore C, Freeman RK, Spong CY. Antenatal testing–a reevaluation: executive summary of a Eunice Kennedy Shriver National Institute of Child Health and Human Development workshop. Obstet Gynecol. 2009;113(3):687-701.
Martin CB. Normal fetal physiology and behavior, and adaptive responses with hypoxemia. Semin Perinatol. 2008;32(4):239-242.
Johnson GJ, Clark SL, Turrentine MA. Antepartum testing for the prevention of stillbirth: where do we go from here?. Obstet Gynecol. 2018;132(6):1407-1411.
American College of Obstetricians and Gynecologists’ Committee on Obstetric Practice and the Society for Maternal-Fetal Medicine. ACOG Committee Opinion, No. 828: indications for outpatient antenatal fetal surveillance. Obstet Gynecol. 2021;137(6):e177-e197.
Sadovsky E, Yaffe H. Daily fetal movement recording and fetal prognosis. Obstet Gynecol. 1973;41(6):845-850.
Bocking AD. Assessment of fetal heart rate and fetal movements in detecting oxygen deprivation in-utero. Eur J Obstet Gynecol Reprod Biol. 2003;110(Suppl 1):S108-S112.
Bellussi F, Po’ G, Livi A. Fetal movement counting and perinatal mortality: a systematic review and meta-analysis. Obstet Gynecol. 2020;135(2):453-462.
Norman JE, Heazell AEP, Rodriguez A; AFFIRM investigators. Awareness of fetal movements and care package to reduce fetal mortality (AFFIRM): a stepped wedge, cluster-randomised trial. Lancet. 2018;392(10158):1629-1638.
Liston R, Sawchuck D, Young D. No. 197a-Fetal health surveillance: antepartum Consensus Guideline. J Obstet Gynaecol Can. 2018;40(4):e251-e271.
Tan KH, Smyth RM, Wei X. Fetal vibroacoustic stimulation for facilitation of tests of fetal wellbeing [Review]. Cochrane Database Syst Rev. 2013(12):CD002963.
Tan KH, Sabapathy A. Maternal glucose administration for facilitating tests of fetal wellbeing [Review]. Cochrane Database Syst Rev. 2001(4):CD003397.
Tan KH, Sabapathy A, Wei X. Fetal manipulation for facilitating tests of fetal wellbeing [Review]. Cochrane Database Syst Rev. 2001(4):CD003396.
Meis PJ, Ureda JR, Swain M, Kelly RT, Penry M, Sharp P. Variable decelerations during nonstress tests are not a sign of fetal compromise. Am J Obstet Gynecol. 1986;154(3):586-590.
Lagrew DC. The contraction stress test. Clin Obstet Gynecol. 1995;38(1):11-25.
Boehm FH, Gabbe SG. Putting it all together. Clin Obstet Gynecol. 2002;45(4):1063-1068.
Practice Bulletin No. 175 Summary: ultrasound in pregnancy. Obstet Gynecol. 2016;128(6):1459-1460.
Magann EF, Isler CM, Chauhan SP, Martin JN. Amniotic fluid volume estimation and the biophysical profile: a confusion of criteria. Obstet Gynecol. 2000;96(4):640-642.
Chauhan SP, Doherty DD, Magann EF, Cahanding F, Moreno F, Klausen JH. Amniotic fluid index vs single deepest pocket technique during modified biophysical profile: a randomized clinical trial. Am J Obstet Gynecol. 2004;191(2):661-667 , discussion 667-668.
Manning FA, Morrison I, Lange IR, Harman CR, Chamberlain PFI. Fetal biophysical profile scoring: selective use of the nonstress test. Am J Obstet Gynecol. 1987;156(3):709-712.
Booker W, Fox NS, Gupta S. Antenatal surveillance in twin pregnancies using the biophysical profile. J Ultrasound Med. 2015;34(11):2071-2075.
